PROTEA - Sectoral Healthcare Opportunities Fund I EUR

Reference Data

ISIN LU1849504649
Valor Number 42469455
Bloomberg Global ID
Fund Name PROTEA - Sectoral Healthcare Opportunities Fund I EUR
Fund Provider Sectoral Asset Management Inc 1010 Sherbrooke St. West, Suite 1610
QC H3A 2R7 Montreal
Canada
Phone: +1 514 849 8777
E-Mail: BusinessDevelopment@sectoral.com
Fund Provider Sectoral Asset Management Inc
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Sub-Fund’s investment objective is long-term growth of capital in USD. In order to achieve this objective, the Sub-Fund invests, while respecting the principle of risk diversification, primarily in equities (including, but not limited to, common stocks, preferred stocks, or other securities convertible into common stock) equity-like transferable securities, depositary receipts such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), participation certificates etc. of small, mid and large cap issuers, located worldwide, in the following healthcare sectors: Healthcare Equipment and Services, Pharmaceuticals, Biotechnology and Lifesciences.
Peculiarities

Fund Prices

Current Price * 416.37 EUR 20.12.2024
Previous Price * 418.44 EUR 19.12.2024
52 Week High * 453.47 EUR 18.10.2024
52 Week Low * 398.40 EUR 22.12.2023
NAV * 416.37 EUR 20.12.2024
Issue Price * 416.37 EUR 20.12.2024
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 98,602,976
Unit/Share Assets *** 17,042,739
Trading Information SIX

Performance

YTD Performance +3.21% 29.12.2023
20.12.2024
YTD Performance (in CHF) +3.58% 29.12.2023
20.12.2024
1 month -2.42% 20.11.2024
20.12.2024
3 months -6.20% 20.09.2024
20.12.2024
6 months -2.78% 20.06.2024
20.12.2024
1 year +6.44% 20.12.2023
20.12.2024
2 years +3.05% 20.12.2022
20.12.2024
3 years +3.14% 20.12.2021
20.12.2024
5 years +37.54% 20.12.2019
20.12.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 9.81%
UnitedHealth Group Inc 8.57%
Novo Nordisk AS Class B 6.33%
Johnson & Johnson 3.41%
AbbVie Inc 3.30%
Pfizer Inc 2.89%
Boston Scientific Corp 2.83%
Abbott Laboratories 2.78%
Bristol-Myers Squibb Co 2.50%
Thermo Fisher Scientific Inc 2.42%
Last data update 30.11.2024

Cost / Risk

TER 0.95%
TER date 30.06.2023
Performance Fee *** 20.00%
PTR
Max. Management Fee *** 0.60%
Ongoing Charges *** 0.92%
SRRI ***
SRRI date *** 30.11.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)